| 9219 |
Quercetin |
TOP2|AO|NonCan:COMT |
Clinical trial |
Clinical trial |
| 36405 |
Chelerythrine |
BCL2|PK:PRKCA,STK |
Clinical trial |
Clinical trial |
| 36586 |
Genistein |
TOP2|PK:YK |
Clinical trial |
Clinical trial |
| 62343 |
3-Bromopyruvate (acid) |
Mito|HK2 |
Clinical trial |
Clinical trial |
| 63984 |
Cordycepin |
Ds |
Clinical trial |
Clinical trial |
| 93766 |
Hydrastinine HCl |
NonCan:Antihemorrhagic |
Clinical trial |
Clinical trial |
| 109874 |
Benzimate |
TUBB |
Clinical trial |
Clinical trial |
| 112907 |
Tetrahydrouridine |
|
Clinical trial |
Clinical trial |
| 116069 |
Cerulenin |
FAS|FASN|HMGCS1/2 |
Clinical trial |
Clinical trial |
| 130181 |
Tirapazamine |
DDI |
Clinical trial |
Clinical trial |
| 142784 |
Tempol |
RP|FRS |
Clinical trial |
Clinical trial |
| 174939 |
Elesclomol |
PK:ROS1 |
Clinical trial |
Clinical trial |
| 217990 |
Pluripotin |
GTPase|RAS|RASA1|PK:STK,MAP3K |
Clinical trial |
Clinical trial |
| 221019 |
Wortmannin |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 255109 |
geldanamycin analog |
HSP90 |
Clinical trial |
Clinical trial |
| 264137 |
Elliptinium Acetate |
TOP2 |
Clinical trial |
Clinical trial |
| 280594 |
Triciribine phosphate |
PK:STK,AKT1 |
Clinical trial |
Clinical trial |
| 281612 |
benzaldehyde (BEN) |
A7 |
Clinical trial |
Clinical trial |
| 308847 |
Amonafide |
TOP2 |
Clinical trial |
Clinical trial |
| 313425 |
Imexon |
Apo |
Clinical trial |
Clinical trial |
| 320846 |
Batracylin |
TOP2|TOP1 |
Clinical trial |
Clinical trial |
| 324360 |
Didox |
|
Clinical trial |
Clinical trial |
| 326231 |
Buthionine sulphoximine |
AM |
Clinical trial |
Clinical trial |
| 330507 |
Tanespimycin |
HSP90 |
Clinical trial |
Clinical trial |
| 350625 |
tic10 |
|
Clinical trial |
Clinical trial |
| 354258 |
8-Chloro-adenosine |
AM |
Clinical trial |
Clinical trial |
| 354462 |
Hypothemycin |
PK:YK,MAP2K1,MAP2K2 |
Clinical trial |
Clinical trial |
| 365798 |
Fostamatinib |
Ds|Rs|PK:YK,SYK |
Clinical trial |
Clinical trial |
| 366140 |
Pyrazoloacridine |
Db |
Clinical trial |
Clinical trial |
| 374551 |
Fenretinide |
Ds |
Clinical trial |
Clinical trial |
| 376128 |
Dolastatin 10 |
TUBB |
Clinical trial |
Clinical trial |
| 377381 |
Antineoplaston A10 |
|
Clinical trial |
Clinical trial |
| 600011 |
Tesmilifene Hydrochloride |
Ho |
Clinical trial |
Clinical trial |
| 609974 |
Carboxyamidotriazole |
AM |
Clinical trial |
Clinical trial |
| 618487 |
Staurosporine |
PK:PRKCA,SRC,Multikinase |
Clinical trial |
Clinical trial |
| 619130 |
Antineoplaston A10 |
|
Clinical trial |
Clinical trial |
| 627168 |
Pyrazoloacridine |
Db |
Clinical trial |
Clinical trial |
| 629749 |
Lapachone |
TOP2|TOP1 |
Clinical trial |
Clinical trial |
| 637037 |
O-6-Benzylguanine |
DDR|MGMT |
Clinical trial |
Clinical trial |
| 638646 |
7-Hydroxystaurosporine |
PK:STK,CDK1,CDK2,CDK4,CDK6 |
Clinical trial |
Clinical trial |
| 638850 |
7-Hydroxystaurosporine |
PK:STK,CDK1,CDK2,CDK4,CDK6 |
Clinical trial |
Clinical trial |
| 639966 |
Perifosine |
PK:STK,AKT,AKT1,AKT2,AKT3 |
Clinical trial |
Clinical trial |
| 648539 |
Antineoplaston A10 |
|
Clinical trial |
Clinical trial |
| 649890 |
Alvocidib |
CCNT1|PK:STK,CDK,CDK1,CDK2,CDK4,CDK6,CDK7,CDK8,CDK9 |
Clinical trial |
Clinical trial |
| 656889 |
XK-469 |
TOP2 |
Clinical trial |
Clinical trial |
| 663249 |
Triapine |
Dr|CC |
Clinical trial |
Clinical trial |
| 668814 |
kahalide f |
|
Clinical trial |
Clinical trial |
| 677083 |
okadaic acid |
Pase |
Clinical trial |
Clinical trial |
| 678515 |
FAU |
Db |
Clinical trial |
Clinical trial |
| 679828 |
PD-98059 |
PK:STK,MAP2K,MAP2K1,MAP2K2 |
Clinical trial |
Clinical trial |
| 684363 |
Epothilone B |
TUBB|Tu-stab |
Clinical trial |
Clinical trial |
| 684681 |
EF-5 |
|
Clinical trial |
Clinical trial |
| 686288 |
Aminoflavone |
Db|DDI |
Clinical trial |
Clinical trial |
| 694501 |
BN-2629 |
Db |
Clinical trial |
Clinical trial |
| 697286 |
LY-294002 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 697726 |
RH1 |
PK:ROS1 |
Clinical trial |
Clinical trial |
| 697887 |
XK-469 |
TOP2 |
Clinical trial |
Clinical trial |
| 697912 |
5-Fluoro deoxy uridine 10mer |
Ds|AM |
Clinical trial |
Clinical trial |
| 698215 |
XK-469 |
TOP2 |
Clinical trial |
Clinical trial |
| 701554 |
Seliciclib |
PK:STK,CDK,CDK2,CDK7,CDK9 |
Clinical trial |
Clinical trial |
| 702827 |
Orantinib |
PK:YK,PDGFR,FGFR,VEGFR,KDR |
Clinical trial |
Clinical trial |
| 703081 |
SL-0101 |
RPS6 |
Clinical trial |
Clinical trial |
| 706995 |
Entinostat |
HDAC |
Clinical trial |
Clinical trial |
| 707545 |
Alvespimycin |
HSP90 |
Clinical trial |
Clinical trial |
| 708298 |
Ar-67 |
TOP1 |
Clinical trial |
Clinical trial |
| 710270 |
Karenitecin |
TOP1 |
Clinical trial |
Clinical trial |
| 710297 |
PX-316 |
PK:STK |
Clinical trial |
Clinical trial |
| 710464 |
AFP464 |
Db|DDI |
Clinical trial |
Clinical trial |
| 713763 |
Rebimastat |
PSM |
Clinical trial |
Clinical trial |
| 714597 |
Imexon |
Apo |
Clinical trial |
Clinical trial |
| 719239 |
E-7820 |
Ang|ITG |
Clinical trial |
Clinical trial |
| 721782 |
D-1MT |
AM|INDO|IDO1|PK:ROS1 |
Clinical trial |
Clinical trial |
| 722134 |
Sonolisib |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 724998 |
LMP-400 |
TOP1 |
Clinical trial |
Clinical trial |
| 725776 |
LMP776 |
TOP1 |
Clinical trial |
Clinical trial |
| 726188 |
IPdR |
|
Clinical trial |
Clinical trial |
| 727859 |
(R)-(-)-Gossypol acetic acid |
Apo|BCL2 |
Clinical trial |
Clinical trial |
| 728165 |
Lificguat |
HYP|HIF1|EPAS1 |
Clinical trial |
Clinical trial |
| 732011 |
SR16157 |
Ho |
Clinical trial |
Clinical trial |
| 734325 |
DMAPT |
NFkB |
Clinical trial |
Clinical trial |
| 737664 |
Veliparib |
PARP|PARP1|PARP2 |
Clinical trial |
Clinical trial |
| 741899 |
BML-277 |
PK:CHEK,CHEK2 |
Clinical trial |
Clinical trial |
| 744912 |
Obatoclax |
Apo|BCL2 |
Clinical trial |
Clinical trial |
| 749712 |
AT-13387 |
HSP90 |
Clinical trial |
Clinical trial |
| 751249 |
Dactolisib |
PK:STK,PIK3,MTOR |
Clinical trial |
Clinical trial |
| 751297 |
Y-27632 |
RHO |
Clinical trial |
Clinical trial |
| 752493 |
Iniparib |
PARP|PARP1|PARP2 |
Clinical trial |
Clinical trial |
| 752840 |
Veliparib |
PARP|PARP1|PARP2 |
Clinical trial |
Clinical trial |
| 754344 |
Rigosertib |
RAS|Tu-stab|PK:STK,PLK1 |
Clinical trial |
Clinical trial |
| 754345 |
JNJ-28312141 |
PK:YK,CSF1R |
Clinical trial |
Clinical trial |
| 754346 |
AMG-458 |
PK:YK,MET |
Clinical trial |
Clinical trial |
| 754347 |
Peptide [CRGDKGPDC - cys & cys bridge |
|
Clinical trial |
Clinical trial |
| 754348 |
PF-03084014 diastereomer 1 |
PSM|APH1|Gamma secretase |
Clinical trial |
Clinical trial |
| 754349 |
Amuvatinib |
RAD51|PK:YK,PDGFR,KIT,FLT3,Multikinase |
Clinical trial |
Clinical trial |
| 754350 |
CB-64D |
Sig2Rec |
Clinical trial |
Clinical trial |
| 754351 |
XL-147 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 754352 |
Adavosertib |
PK:STK,YK,WEE1 |
Clinical trial |
Clinical trial |
| 754353 |
Buparlisib |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 754354 |
GSK-461364 |
PK:STK,PLK1 |
Clinical trial |
Clinical trial |
| 754356 |
PF-562271 |
PK:YK,FAK |
Clinical trial |
Clinical trial |
| 754357 |
RAF-265 |
GTPase|PK:BRAF |
Clinical trial |
Clinical trial |
| 754358 |
TDP-665759 |
Apo|MDM2 |
Clinical trial |
Clinical trial |
| 754359 |
AEG-40730 |
Apo|IAP |
Clinical trial |
Clinical trial |
| 754360 |
MI-219 |
Apo|MDM2 |
Clinical trial |
Clinical trial |
| 754361 |
Astex FGF inhibitor |
PK:YK,FGFR |
Clinical trial |
Clinical trial |
| 754362 |
SB-590885 |
GTPase|PK:YK,BRAF |
Clinical trial |
Clinical trial |
| 754364 |
Targegen B-Raf/PDGFR inhibitor Cpd 6 |
GTPase|PK:YK,PDGFR,BRAF |
Clinical trial |
Clinical trial |
| 754365 |
XR-11576 |
TOP2|TOP1 |
Clinical trial |
Clinical trial |
| 754366 |
XR-5944 |
TOP2|TOP1 |
Clinical trial |
Clinical trial |
| 754367 |
XR-5000 |
TOP2|TOP1 |
Clinical trial |
Clinical trial |
| 755385 |
Pictilisib |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 755386 |
Ispinesib |
TUBB|CC|CDH16|KIF11|Kinesin|PK:YK |
Clinical trial |
Clinical trial |
| 755387 |
Sepantronium bromide |
Apo|BIRC5 |
Clinical trial |
Clinical trial |
| 755388 |
Fenoprofen |
|
Clinical trial |
Clinical trial |
| 755402 |
Meclofenamate |
|
Clinical trial |
Clinical trial |
| 755761 |
XAV-939 |
Wnt|PK:YK,TNKS |
Clinical trial |
Clinical trial |
| 755762 |
Luminespib |
HSP90 |
Clinical trial |
Clinical trial |
| 755763 |
Pimasertib |
PK:STK,YK,MAP2K,MAP2K1,MAP2K2 |
Clinical trial |
Clinical trial |
| 755765 |
GW-5074 |
GTPase|PK:RAF,RAF1 |
Clinical trial |
Clinical trial |
| 755766 |
H-89 |
Protein kinase A|PK:STK,AKT1 |
Clinical trial |
Clinical trial |
| 755769 |
LY-294002 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 755770 |
PD-0325901 |
PK:STK,MAP2K,MAP2K1 |
Clinical trial |
Clinical trial |
| 755771 |
Salirasib |
GTPase|RAS|PK:YK,MTOR |
Clinical trial |
Clinical trial |
| 755772 |
SB-203580 |
PK:STK,MAPK14,PDK1 |
Clinical trial |
Clinical trial |
| 755773 |
1,9-Pyrazoleanthrone |
PK:STK,MAPK14,MAPK8 |
Clinical trial |
Clinical trial |
| 755774 |
Staurosporine |
PK:PRKCA,SRC,Multikinase |
Clinical trial |
Clinical trial |
| 755775 |
Foretinib |
PK:YK,MET,AXL,VEGFR,KDR,RON,Multikinase |
Clinical trial |
Clinical trial |
| 755806 |
XL-147 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 755807 |
Dactolisib |
PK:STK,PIK3,MTOR |
Clinical trial |
Clinical trial |
| 755892 |
Hydrastinine HCl |
NonCan:Antihemorrhagic |
Clinical trial |
Clinical trial |
| 755926 |
PF-03084014 diastereomer 1 |
PSM|APH1|Gamma secretase |
Clinical trial |
Clinical trial |
| 755927 |
WZ-4002 |
PK:YK,EGFR |
Clinical trial |
Clinical trial |
| 755981 |
WP-1034 |
STAT|PK:YK,JAK |
Clinical trial |
Clinical trial |
| 755982 |
Semagacestat |
PSM|APH1|Gamma secretase |
Clinical trial |
Clinical trial |
| 755983 |
BI-2536 |
PK:STK,PLK1 |
Clinical trial |
Clinical trial |
| 756641 |
ICG-001 |
Apo|Wnt|CTNNB1 |
Clinical trial |
Clinical trial |
| 756642 |
Entinostat |
HDAC |
Clinical trial |
Clinical trial |
| 756646 |
IWR-1 |
Wnt|CTNNB1 |
Clinical trial |
Clinical trial |
| 756648 |
AZD-1480 |
PK:YK,JAK,JAK1,JAK2 |
Clinical trial |
Clinical trial |
| 756649 |
SB-431542 |
TGFB1|PK:STK,GSK3B |
Clinical trial |
Clinical trial |
| 756650 |
RO-4929097 |
PSM|APH1|Gamma secretase |
Clinical trial |
Clinical trial |
| 756651 |
Custom Peptide 835899 |
FGF|Protein kinase A|BAD|YWHA|PK:YK,PDGFR,RAF,VEGFR,MAP3K5 |
Clinical trial |
Clinical trial |
| 756652 |
Linsitinib |
PK:YK,IGF1R |
Clinical trial |
Clinical trial |
| 756653 |
SB-239063 |
PK:STK,MAPK14 |
Clinical trial |
Clinical trial |
| 756654 |
ZM-336372 |
GTPase|PK:BRAF,RAF,RAF1 |
Clinical trial |
Clinical trial |
| 756657 |
OSU-03012 |
PK:STK,PDK1 |
Clinical trial |
Clinical trial |
| 756658 |
OSU-03013 |
PK:STK,PDK1 |
Clinical trial |
Clinical trial |
| 756660 |
Quercetin |
TOP2|AO|NonCan:COMT |
Clinical trial |
Clinical trial |
| 756662 |
sr 13654 |
BIRC5|PK:YK |
Clinical trial |
Clinical trial |
| 756663 |
Obatoclax |
Apo|BCL2 |
Clinical trial |
Clinical trial |
| 756874 |
NU-6027 |
PK:STK,ATR |
Clinical trial |
Clinical trial |
| 756875 |
(+/-)-Nutlin-3 |
Apo|MDM2 |
Clinical trial |
Clinical trial |
| 756876 |
(-)-Nutlin-3 |
Apo|MDM2 |
Clinical trial |
Clinical trial |
| 756877 |
1st Precursor Intermediate to TDP 665759 |
Apo|MDM2 |
Clinical trial |
Clinical trial |
| 756878 |
2nd Precursor Intermediate to TDP 665759 |
Apo|MDM2 |
Clinical trial |
Clinical trial |
| 756879 |
Lificguat |
HYP|HIF1|EPAS1 |
Clinical trial |
Clinical trial |
| 757148 |
AZD-7762 |
PK:STK,CHEK,CHEK1,CHEK2 |
Clinical trial |
Clinical trial |
| 757149 |
Volasertib |
PK:STK,PLK1 |
Clinical trial |
Clinical trial |
| 757333 |
SGI-1776 |
PK:STK,PIM1 |
Clinical trial |
Clinical trial |
| 757334 |
Cpd-401 |
STAT|STAT3 |
Clinical trial |
Clinical trial |
| 757438 |
PLX-4720 |
GTPase|PK:BRAF |
Clinical trial |
Clinical trial |
| 757440 |
Deforolimius |
PK:STK,MTOR |
Clinical trial |
Clinical trial |
| 757444 |
Barasertib |
PK:STK,AURK |
Clinical trial |
Clinical trial |
| 758005 |
Sapitinib |
PK:YK,EGFR,ERBB2 |
Clinical trial |
Clinical trial |
| 758006 |
BLZ-945 |
PK:CSF1R |
Clinical trial |
Clinical trial |
| 758242 |
Tivantinib |
PK:YK,MET |
Clinical trial |
Clinical trial |
| 758243 |
BMS-754807 |
PK:YK,IGF1R |
Clinical trial |
Clinical trial |
| 758245 |
ENMD-2076 |
PK:STK,AURK,KDR |
Clinical trial |
Clinical trial |
| 758248 |
RO-5126766 |
GTPase|PK:STK,YK,BRAF,MAP2K,RAF,MAP2K1,MAP2K2 |
Clinical trial |
Clinical trial |
| 758249 |
Pracinostat |
HDAC |
Clinical trial |
Clinical trial |
| 758250 |
SNS-314 |
PK:STK,AURK |
Clinical trial |
Clinical trial |
| 758251 |
Amonafide |
TOP2 |
Clinical trial |
Clinical trial |
| 758256 |
PKI-587 |
PK:STK,PIK3,MTOR |
Clinical trial |
Clinical trial |
| 758257 |
LY-2606368 |
PK:STK,CHEK,CHEK1 |
Clinical trial |
Clinical trial |
| 758484 |
Ezatiostat |
GSTP1|PK:STK,ROS1 |
Clinical trial |
Clinical trial |
| 758485 |
BX-912 |
PK:STK,PDK1 |
Clinical trial |
Clinical trial |
| 758486 |
HPI-1 |
SMO|Hg-Smo |
Clinical trial |
Clinical trial |
| 758488 |
Lexibulin |
TUBB|Tu-frag|Tu-stab |
Clinical trial |
Clinical trial |
| 758489 |
Indibulin |
TUBB|Tu-frag|PK:PTK |
Clinical trial |
Clinical trial |
| 758490 |
Picoplatin |
A7|CC|AlkAg|IDNARep |
Clinical trial |
Clinical trial |
| 758591 |
SGX-523 |
PK:YK,MET |
Clinical trial |
Clinical trial |
| 758773 |
Varbulin |
TUBB|Tu-frag |
Clinical trial |
Clinical trial |
| 758871 |
AZD-8055 |
PK:STK,MTOR |
Clinical trial |
Clinical trial |
| 758872 |
Saracatinib |
PK:YK,FYN,LYN,FGFR,SRC,BLK,LCK,YES1 |
Clinical trial |
Clinical trial |
| 758873 |
ABT-737 |
Apo|BCL2 |
Clinical trial |
Clinical trial |
| 759094 |
ENMD-2076 Precursor |
PK:STK,AURK |
Clinical trial |
Clinical trial |
| 759095 |
JNJ-38877605 |
PK:YK,MET |
Clinical trial |
Clinical trial |
| 759096 |
Triapine |
Dr|CC |
Clinical trial |
Clinical trial |
| 759498 |
CYC-116 |
PK:STK,AURK |
Clinical trial |
Clinical trial |
| 759657 |
Quisinostat |
HDAC |
Clinical trial |
Clinical trial |
| 759658 |
6-(4-pyrimidinyl)-1H-indazole derivative |
PK:STK,PDK1 |
Clinical trial |
Clinical trial |
| 759659 |
Navitoclax |
Apo|BCL2 |
Clinical trial |
Clinical trial |
| 759660 |
OSI-027 |
PK:STK,MTOR |
Clinical trial |
Clinical trial |
| 759661 |
Dovitinib |
PK:YK,MET,PDGFR,EGFR,FGFR,KIT,VEGFR,FGFR1,FGFR3,FLT3 |
Clinical trial |
Clinical trial |
| 759674 |
Pacritinib |
PK:YK,JAK,JAK2 |
Clinical trial |
Clinical trial |
| 759675 |
KW-2449 |
BCR-ABL|PK:STK,AURK,FLT,FLT3 |
Clinical trial |
Clinical trial |
| 759676 |
PI-103 |
PK:PIK3,MTOR |
Clinical trial |
Clinical trial |
| 759677 |
Alisertib |
PK:STK,AURK |
Clinical trial |
Clinical trial |
| 759905 |
4SC-202 |
HDAC |
Clinical trial |
Clinical trial |
| 760143 |
Mocetinostat |
HDAC |
Clinical trial |
Clinical trial |
| 760144 |
AT-9283 |
PK:STK,AURK |
Clinical trial |
Clinical trial |
| 760183 |
(+)-JQ1 |
BRD |
Clinical trial |
Clinical trial |
| 760419 |
Fenretinide |
Ds |
Clinical trial |
Clinical trial |
| 760442 |
Daporinad |
NAMPT|PK:YK |
Clinical trial |
Clinical trial |
| 760444 |
Tipifarnib |
FT|PK:YK |
Clinical trial |
Clinical trial |
| 760536 |
PF-04691502 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 760765 |
BMS-690514 |
PK:YK,EGFR,ERBB2,VEGFR |
Clinical trial |
Clinical trial |
| 760841 |
Tandutinib |
PK:YK,PDGFR,FLT,KIT,FLT3 |
Clinical trial |
Clinical trial |
| 760842 |
BIM-46187 |
Apo|GTPase|CASP |
Clinical trial |
Clinical trial |
| 760843 |
Motesanib |
PK:YK,PDGFR,KIT,VEGFR,KDR,RET |
Clinical trial |
Clinical trial |
| 761069 |
AMG-900 |
PK:STK,AURK |
Clinical trial |
Clinical trial |
| 761070 |
VE-821 |
PK:STK,ATR |
Clinical trial |
Clinical trial |
| 761188 |
Rabusertib |
PK:STK,CHEK,CHEK1 |
Clinical trial |
Clinical trial |
| 761189 |
Teglarinad |
Apo|NAMPT |
Clinical trial |
Clinical trial |
| 761192 |
Pevonedistat |
NFkB|NEDD8 |
Clinical trial |
Clinical trial |
| 761193 |
Silmitasertib |
CK2|PK:STK |
Clinical trial |
Clinical trial |
| 761194 |
CUDC-305 |
HSP90 |
Clinical trial |
Clinical trial |
| 761215 |
TAK-733 |
PK:STK,MAP2K,MAP2K1,MAP2K2 |
Clinical trial |
Clinical trial |
| 761216 |
Galunisertib |
TGFB1|PK:GSK3B |
Clinical trial |
Clinical trial |
| 761217 |
Avagacestat |
PSM|APH1|Gamma secretase |
Clinical trial |
Clinical trial |
| 761266 |
Motexafin |
Dr|TXNRD|PK:ROS1 |
Clinical trial |
Clinical trial |
| 761387 |
CCT-128930 |
PK:STK,AKT,AKT1,AKT2,AKT3 |
Clinical trial |
Clinical trial |
| 761390 |
By-Product of CUDC-305 |
HSP90 |
Clinical trial |
Clinical trial |
| 761690 |
CP-91149 |
PYGL |
Clinical trial |
Clinical trial |
| 761691 |
SCH-1473759 |
PK:STK,AURK |
Clinical trial |
Clinical trial |
| 761692 |
MK-8033 |
PK:YK,MET |
Clinical trial |
Clinical trial |
| 761693 |
Vertex ATR inhibitor Cpd 45 |
PK:STK,ATR |
Clinical trial |
Clinical trial |
| 761759 |
TAK-960 analog |
PK:STK,PLK1 |
Clinical trial |
Clinical trial |
| 761760 |
BMS-536924 |
PK:YK,IGF1R |
Clinical trial |
Clinical trial |
| 761879 |
ITRI-260 |
PK:YK,FLT,FLT3 |
Clinical trial |
Clinical trial |
| 761931 |
KHK-Indazole |
PK:YK,IGF1R |
Clinical trial |
Clinical trial |
| 762151 |
TAK-901 |
PK:STK,AURK |
Clinical trial |
Clinical trial |
| 762152 |
ONX-0914 |
PSM |
Clinical trial |
Clinical trial |
| 762153 |
ST-3595 |
HDAC |
Clinical trial |
Clinical trial |
| 762154 |
Des-fluoro-TAK-960 |
PK:STK,PLK1 |
Clinical trial |
Clinical trial |
| 762381 |
CGI Diphenylurea PK inhibitor |
PK:YK,EPHA4,PDGFR,VEGFR |
Clinical trial |
Clinical trial |
| 762382 |
CH-5132799 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 762418 |
TAK Plk inhibitor |
PK:STK,PLK1 |
Clinical trial |
Clinical trial |
| 762419 |
CT-32228 |
AGPAT2|PK:YK,VEGFR |
Clinical trial |
Clinical trial |
| 762521 |
RO-4987655 |
PK:STK,MAP2K |
Clinical trial |
Clinical trial |
| 762598 |
BAL-27862 |
TUBB|Tu-frag |
Clinical trial |
Clinical trial |
| 762672 |
BMS-299897 |
PSM|APH1|Gamma secretase |
Clinical trial |
Clinical trial |
| 762673 |
SB-1317 |
PK:STK,CDK,ERK,FLT,JAK,FLT3 |
Clinical trial |
Clinical trial |
| 762829 |
MK-0752 |
PSM|APH1|Gamma secretase |
Clinical trial |
Clinical trial |
| 762831 |
MK-0752 |
PSM|APH1|Gamma secretase |
Clinical trial |
Clinical trial |
| 763094 |
JZL-184 |
MGLL |
Clinical trial |
Clinical trial |
| 763443 |
(+)-Nutlin-3 |
Apo|MDM2 |
Clinical trial |
Clinical trial |
| 763444 |
PF-477736 |
PK:STK,CHEK,CHEK1 |
Clinical trial |
Clinical trial |
| 763525 |
Pluripotin |
GTPase|RAS|RASA1|PK:STK,MAP3K |
Clinical trial |
Clinical trial |
| 763526 |
Crenolanib |
PK:YK,PDGFR,KIT,VEGFR,TEK,FLT3 |
Clinical trial |
Clinical trial |
| 763527 |
JZL-195 |
MGLL |
Clinical trial |
Clinical trial |
| 763564 |
EMD-534085 |
CDH16|KIF11|Kinesin|PK:YK |
Clinical trial |
Clinical trial |
| 763579 |
AT-13387 |
HSP90 |
Clinical trial |
Clinical trial |
| 763758 |
SEN-450 |
SMO |
Clinical trial |
Clinical trial |
| 763832 |
LOR-253 |
KLF4|MYC|MTF1 |
Clinical trial |
Clinical trial |
| 763929 |
Orantinib |
PK:YK,PDGFR,FGFR,VEGFR,KDR |
Clinical trial |
Clinical trial |
| 763930 |
AS-703569 |
PK:AURK |
Clinical trial |
Clinical trial |
| 763931 |
PF-04217903 |
PK:MET |
Clinical trial |
Clinical trial |
| 764036 |
Dinaciclib |
PK:STK,CDK,CDK1,CDK2,CDK5,CDK9 |
Clinical trial |
Clinical trial |
| 764037 |
BP-1-102 |
STAT|IL6|STAT3 |
Clinical trial |
Clinical trial |
| 764039 |
AZD-5363 |
PK:STK,AKT,AKT1,AKT2,AKT3 |
Clinical trial |
Clinical trial |
| 764041 |
TAE-684 |
PK:YK,ALK |
Clinical trial |
Clinical trial |
| 764043 |
(+)-JQ1 |
BRD |
Clinical trial |
Clinical trial |
| 764090 |
BMS-777607 |
PK:MET,RON |
Clinical trial |
Clinical trial |
| 764091 |
Apitolisib |
PK:PIK3,MTOR |
Clinical trial |
Clinical trial |
| 764092 |
GSK-2126458 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 764135 |
BMS-599626 |
PK:YK,EGFR,ERBB2 |
Clinical trial |
Clinical trial |
| 764136 |
Abexinostat |
HDAC |
Clinical trial |
Clinical trial |
| 764237 |
Linifanib |
PK:YK,CSF1R,PDGFR,VEGFR,FLT3,KDR |
Clinical trial |
Clinical trial |
| 764238 |
6-Bromoindirubin-3'-Acetoxime |
PK:GSK3A |
Clinical trial |
Clinical trial |
| 764239 |
AZD-4547 |
PK:YK,FGFR,FGFR1,FGFR2,FGFR3 |
Clinical trial |
Clinical trial |
| 764276 |
t-dcyd |
|
Clinical trial |
Clinical trial |
| 764334 |
delanzomib |
PSM |
Clinical trial |
Clinical trial |
| 764481 |
Brivanib |
PK:YK,FGFR,VEGFR,FGFR1,FGFR2,FGFR3,KDR |
Clinical trial |
Clinical trial |
| 764488 |
Orteronel |
CYP17A1 |
Clinical trial |
Clinical trial |
| 764515 |
PP-242 |
PK:MTOR |
Clinical trial |
Clinical trial |
| 764516 |
ZSTK-474 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 764517 |
UNC-0638 |
EHMT2|EHMT1/2 |
Clinical trial |
Clinical trial |
| 764579 |
Inolitazone hydrochloride |
PPARG |
Clinical trial |
Clinical trial |
| 764580 |
MK-2461 |
PK:MET,FGFR |
Clinical trial |
Clinical trial |
| 764582 |
10058-F4 |
MYC |
Clinical trial |
Clinical trial |
| 764608 |
BAL-101553 |
Tu-frag |
Clinical trial |
Clinical trial |
| 764609 |
10074-G5 |
MYC |
Clinical trial |
Clinical trial |
| 764658 |
INK-128 |
PK:MTOR |
Clinical trial |
Clinical trial |
| 764659 |
SCH-900776 |
PK:STK,CHEK,CHEK1 |
Clinical trial |
Clinical trial |
| 764755 |
Cerulenin |
FAS|FASN|HMGCS1/2 |
Clinical trial |
Clinical trial |
| 764756 |
C-75 |
FAS|FASN |
Clinical trial |
Clinical trial |
| 764757 |
SM-406 |
IAP |
Clinical trial |
Clinical trial |
| 764764 |
ONX-0801 |
TYMS |
Clinical trial |
Clinical trial |
| 764765 |
ARQ-680 |
PK:BRAF |
Clinical trial |
Clinical trial |
| 764820 |
Gandotinib |
PK:JAK,JAK2,JAK3 |
Clinical trial |
Clinical trial |
| 764823 |
Varlitinib |
PK:YK,EGFR,ERBB2 |
Clinical trial |
Clinical trial |
| 765262 |
R-428 |
PK:AXL |
Clinical trial |
Clinical trial |
| 765395 |
MPC-3100 |
HSP90 |
Clinical trial |
Clinical trial |
| 765435 |
Ganetespib |
HSP90 |
Clinical trial |
Clinical trial |
| 765436 |
YK-4-279 |
ERG|ETV |
Clinical trial |
Clinical trial |
| 765632 |
LY-2109761 |
TGFB1|PK:GSK3B |
Clinical trial |
Clinical trial |
| 765672 |
S-49076 |
PK:MET,AXL,FGFR,MERTK |
Clinical trial |
Clinical trial |
| 765673 |
Litronesib |
TUBB|CDH16|KIF11 |
Clinical trial |
Clinical trial |
| 765695 |
PD 184352 |
PK:MAP2K |
Clinical trial |
Clinical trial |
| 765775 |
Gemcitabine elaidate |
Ds |
Clinical trial |
Clinical trial |
| 765776 |
AZD-3514 |
AR |
Clinical trial |
Clinical trial |
| 765865 |
ASP-3026 |
PK:ALK |
Clinical trial |
Clinical trial |
| 765866 |
Refametinib |
PK:MAP2K,MAP2K1,MAP2K2 |
Clinical trial |
Clinical trial |
| 765889 |
ABT-348 |
PK:AURK,VEGFR |
Clinical trial |
Clinical trial |
| 765898 |
GDC-0152 |
IAP |
Clinical trial |
Clinical trial |
| 765949 |
AEE-788 |
PK:EGFR,ERBB2,VEGF,VEGFR |
Clinical trial |
Clinical trial |
| 766254 |
Oprozomib |
PSM |
Clinical trial |
Clinical trial |
| 766255 |
CT-GSK183 |
PK:IGF1R,ALK |
Clinical trial |
Clinical trial |
| 766271 |
PHA-665752 |
PK:MET |
Clinical trial |
Clinical trial |
| 766288 |
AMG-208 |
PK:MET |
Clinical trial |
Clinical trial |
| 766811 |
Odanacatib |
CTSB |
Clinical trial |
Clinical trial |
| 766819 |
Sotrastaurin |
PK:PRKCA |
Clinical trial |
Clinical trial |
| 766820 |
LY-2228820 |
PK:MAPK14 |
Clinical trial |
Clinical trial |
| 766821 |
BMS-911543 |
PK:JAK,JAK1,JAK2,JAK3 |
Clinical trial |
Clinical trial |
| 766824 |
CEP-14083 |
PK:ALK |
Clinical trial |
Clinical trial |
| 766887 |
OSI-930 |
PK:PDGFR,KIT,VEGFR,Multikinase |
Clinical trial |
Clinical trial |
| 766888 |
BBOA |
AEMD |
Clinical trial |
Clinical trial |
| 766906 |
MLN-2480 |
PK:BRAF,RAF,RAF1 |
Clinical trial |
Clinical trial |
| 766908 |
PD 173074 |
PK:PDGFR,FGFR,SRC,VEGFR,FGFR1,FGFR3 |
Clinical trial |
Clinical trial |
| 766991 |
GSK-690693 |
PK:AKT,AKT1,AKT2,AKT3 |
Clinical trial |
Clinical trial |
| 766992 |
BAY 61-3606 |
PK:SYK |
Clinical trial |
Clinical trial |
| 767006 |
AEW-541 |
PK:YK,IGF1R |
Clinical trial |
Clinical trial |
| 767048 |
BMS-387032 |
PK:CDK,CDK2,CDK7,CDK9 |
Clinical trial |
Clinical trial |
| 767123 |
Saridegib |
SMO |
Clinical trial |
Clinical trial |
| 767124 |
Enzastaurin |
PK:PRKCA,STK,PIK3,AKT |
Clinical trial |
Clinical trial |
| 767126 |
LEQ-506 |
SMO |
Clinical trial |
Clinical trial |
| 767128 |
Birinapant |
IAP |
Clinical trial |
Clinical trial |
| 767189 |
AZD-2014 |
PK:MTOR |
Clinical trial |
Clinical trial |
| 767470 |
MLN-0905 |
PK:PLK1 |
Clinical trial |
Clinical trial |
| 767533 |
BMN-673 enantiomer |
PARP1 |
Clinical trial |
Clinical trial |
| 767598 |
Momelotinib |
PK:JAK,JAK1,JAK2,JAK3 |
Clinical trial |
Clinical trial |
| 767599 |
I-BET-151 |
BRD |
Clinical trial |
Clinical trial |
| 767601 |
VX-944 |
IMPDH2|IMPDH1|IMPDH |
Clinical trial |
Clinical trial |
| 767745 |
Pelitrexol |
GARTF |
Clinical trial |
Clinical trial |
| 767746 |
ADW-742 |
PK:IGF1R,KIT |
Clinical trial |
Clinical trial |
| 767896 |
LY-2940680 |
SMO |
Clinical trial |
Clinical trial |
| 767897 |
BPR1J-097 |
PK:FLT,FLT3 |
Clinical trial |
Clinical trial |
| 767898 |
ipatasertib |
PK:AKT,AKT1,AKT2,AKT3 |
Clinical trial |
Clinical trial |
| 767951 |
GSK-1904529A |
PK:IGF1R |
Clinical trial |
Clinical trial |
| 767952 |
rocilinostat |
HDAC |
Clinical trial |
Clinical trial |
| 767953 |
R-1530 |
PK:PDGFR,CDK,FGFR,VEGFR,KDR,Multikinase |
Clinical trial |
Clinical trial |
| 767954 |
EMD-1204831 |
PK:MET |
Clinical trial |
Clinical trial |
| 768011 |
XL-541 |
GEMIN2 |
Clinical trial |
Clinical trial |
| 768070 |
enantiomer of PF-4176340 |
PK:AKT |
Clinical trial |
Clinical trial |
| 768071 |
enantiomer of PF-4176340 |
PK:AKT |
Clinical trial |
Clinical trial |
| 768072 |
TAK-960 |
PK:PLK1 |
Clinical trial |
Clinical trial |
| 768100 |
SAR-245409 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 768112 |
SAR-402674 |
TOP1 |
Clinical trial |
Clinical trial |
| 768508 |
GSK-2636771 |
PK:PIK3,MTOR |
Clinical trial |
Clinical trial |
| 768509 |
SNX-5422 |
HSP90 |
Clinical trial |
Clinical trial |
| 768536 |
BAM7 |
BCL2 |
Clinical trial |
Clinical trial |
| 768539 |
IDH1-Comp 301 |
IDH1 |
Clinical trial |
Clinical trial |
| 768593 |
CEP-9722 |
PARP1 |
Clinical trial |
Clinical trial |
| 771531 |
RG-7112 |
MDM2 |
Clinical trial |
Clinical trial |
| 771532 |
GDC-0349 |
PK:MTOR,PIM3 |
Clinical trial |
Clinical trial |
| 771644 |
ARQ-621 |
CDH16|KIF11 |
Clinical trial |
Clinical trial |
| 771650 |
AT-13148 |
PK:AKT,AKT1,AKT2,AKT3 |
Clinical trial |
Clinical trial |
| 771651 |
VX-322 |
PK:FLT,KIT,FLT3 |
Clinical trial |
Clinical trial |
| 771652 |
SAR-125844 |
PK:MET |
Clinical trial |
Clinical trial |
| 771750 |
LY-2874455 |
PK:FGFR,VEGFR,FGFR1,FGFR2,FGFR3,FGFR4 |
Clinical trial |
Clinical trial |
| 771751 |
CUDC-907 |
HDAC|PK:PIK3 |
Clinical trial |
Clinical trial |
| 771858 |
TAK-441 |
SMO |
Clinical trial |
Clinical trial |
| 772196 |
Lestaurtinib |
PK:YK,FLT,NTRK,FLT3,JAK2 |
Clinical trial |
Clinical trial |
| 772197 |
LY-2801653 |
PK:MET,AXL,FLT3,MERTK,MST1R,Multikinase |
Clinical trial |
Clinical trial |
| 772198 |
LY-2090314 |
PK:GSK3A,GSK3B |
Clinical trial |
Clinical trial |
| 772254 |
ARRY-520 Isomer A |
CDH16 |
Clinical trial |
Clinical trial |
| 772255 |
ARRY-520 Isomer A |
CDH16 |
Clinical trial |
Clinical trial |
| 772290 |
Pelitrexol isomer A |
GARTF |
Clinical trial |
Clinical trial |
| 772291 |
Pelitrexol isomer B |
GARTF |
Clinical trial |
Clinical trial |
| 772351 |
XL-888 |
HSP90 |
Clinical trial |
Clinical trial |
| 772498 |
r406 |
PK:SYK |
Clinical trial |
Clinical trial |
| 772499 |
Vatalanib |
CYP19A1|PK:YK,PDGFR,KIT,VEGFR,KDR |
Clinical trial |
Clinical trial |
| 772563 |
ARRY-704 |
PK:MAP2K,MAP2K1,MAP2K2 |
Clinical trial |
Clinical trial |
| 772564 |
IDH-C227 |
IDH1 |
Clinical trial |
Clinical trial |
| 772595 |
KPT-185 |
XPO1 |
Clinical trial |
Clinical trial |
| 772868 |
LCL-161 |
IAP |
Clinical trial |
Clinical trial |
| 772885 |
PF-4942847 |
HSP90 |
Clinical trial |
Clinical trial |
| 772886 |
Apatinib |
PK:VEGFR |
Clinical trial |
Clinical trial |
| 772887 |
XL-019 |
PK:JAK,JAK2 |
Clinical trial |
Clinical trial |
| 772920 |
ONX-0805 |
PK:JAK,JAK2 |
Clinical trial |
Clinical trial |
| 772991 |
PKM2 (9) |
PKM |
Clinical trial |
Clinical trial |
| 772992 |
Fostamatinib |
Ds|Rs|PK:YK,SYK |
Clinical trial |
Clinical trial |
| 773094 |
R-547 |
PK:CDK,CDK1,CDK2,CDK4 |
Clinical trial |
Clinical trial |
| 773095 |
BGT-226 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 773096 |
IDH-C35 |
IDH1 |
Clinical trial |
Clinical trial |
| 773174 |
LDHA Inhibitor-33 |
LDHA |
Clinical trial |
Clinical trial |
| 773230 |
AZD-2461 |
PARP1|PARP2 |
Clinical trial |
Clinical trial |
| 773260 |
KPT-251 |
XPO1 |
Clinical trial |
Clinical trial |
| 773261 |
GSK-921 |
CDH16|KIF11 |
Clinical trial |
Clinical trial |
| 773262 |
VX-689 |
PK:AURK |
Clinical trial |
Clinical trial |
| 773263 |
Bafetinib |
BCR-ABL|PK:YK,FYN,LYN |
Clinical trial |
Clinical trial |
| 773264 |
R-306465 |
HDAC |
Clinical trial |
Clinical trial |
| 773265 |
B-7100 |
HSP90 |
Clinical trial |
Clinical trial |
| 773394 |
AT-7519 |
RNA polymerase I|PK:CDK,CDK1,CDK2,CDK4,CDK6 |
Clinical trial |
Clinical trial |
| 774651 |
Cilengitide |
Ang|ITG |
Clinical trial |
Clinical trial |
| 774829 |
I-BET-762 |
BRD |
Clinical trial |
Clinical trial |
| 774830 |
Milciclib |
PK:CDK,CDK1,CDK2,CDK4,CDK5,Multikinase |
Clinical trial |
Clinical trial |
| 774831 |
Rebastinib |
BCR-ABL|PK:LYN,FGFR,SRC,VEGFR,TEK |
Clinical trial |
Clinical trial |
| 774901 |
AZD-2858 |
Wnt|PK:GSK3A |
Clinical trial |
Clinical trial |
| 774911 |
BAY-1000394 |
PK:CDK |
Clinical trial |
Clinical trial |
| 775018 |
LDHA Cmp 35 |
LDHA |
Clinical trial |
Clinical trial |
| 775306 |
P-529 |
PK:PIK3,AKT,FGFR,MTOR,VEGFR |
Clinical trial |
Clinical trial |
| 775636 |
SCH-772984 |
PK:ERK,MAP3K,MAPK1 |
Clinical trial |
Clinical trial |
| 775637 |
AMD-070 |
CXCR4 |
Clinical trial |
Clinical trial |
| 775665 |
VX-702 |
PK:MAPK14 |
Clinical trial |
Clinical trial |
| 775727 |
Torin2 |
PK:MTOR |
Clinical trial |
Clinical trial |
| 775771 |
BMS-863233 |
PK:CDC7,CDK7,CDK9 |
Clinical trial |
Clinical trial |
| 775790 |
maritoclax |
MCL1 |
Clinical trial |
Clinical trial |
| 776017 |
Telatinib |
PK:PDGFR,KIT,VEGFR,KDR |
Clinical trial |
Clinical trial |
| 776043 |
CEP-32496 |
PK:BRAF |
Clinical trial |
Clinical trial |
| 776066 |
AZD-1208 |
PK:PIM1,PIM2,PIM3 |
Clinical trial |
Clinical trial |
| 776762 |
EXEL-7647 |
PK:EGFR,ERBB2,SRC,VEGFR |
Clinical trial |
Clinical trial |
| 776786 |
P505-15 |
PK:SYK |
Clinical trial |
Clinical trial |
| 776787 |
AZD-3463 |
PK:IGF1R,ALK |
Clinical trial |
Clinical trial |
| 776790 |
MK-0429 |
ITG |
Clinical trial |
Clinical trial |
| 776821 |
CCT-241533 |
PK:CHEK,CHEK2 |
Clinical trial |
Clinical trial |
| 776996 |
PI-103 |
PK:PIK3,MTOR |
Clinical trial |
Clinical trial |
| 777194 |
Daporinad |
NAMPT|PK:YK |
Clinical trial |
Clinical trial |
| 777425 |
GDC-0032 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 777445 |
GSK-1070916 |
PK:AURK |
Clinical trial |
Clinical trial |
| 777446 |
Talmapimod |
PK:MAPK14 |
Clinical trial |
Clinical trial |
| 777447 |
VTX-2337 |
TLR8 |
Clinical trial |
Clinical trial |
| 777448 |
PFI-1 |
BRD |
Clinical trial |
Clinical trial |
| 777571 |
BIX-01294 |
EHMT2|EHMT1/2 |
Clinical trial |
Clinical trial |
| 777572 |
AZD-8186 |
PI3KB|PK:PIK3 |
Clinical trial |
Clinical trial |
| 777573 |
E-7820 |
Ang|ITG |
Clinical trial |
Clinical trial |
| 777586 |
5-aza-T-dCyd |
|
Clinical trial |
Clinical trial |
| 777638 |
AZD-6738 |
PK:ATR |
Clinical trial |
Clinical trial |
| 777639 |
LGK-974 |
Wnt|PORCN |
Clinical trial |
Clinical trial |
| 777671 |
BRD-4770 |
EHMT2|EHMT1/2 |
Clinical trial |
Clinical trial |
| 777718 |
VE-822 |
PK:ATR |
Clinical trial |
Clinical trial |
| 777877 |
PF-4989216 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 777879 |
AM-5992 |
PK:CDK,FLT,FLT3 |
Clinical trial |
Clinical trial |
| 778305 |
Afuresertib |
PK:AKT,AKT1,AKT2,AKT3 |
Clinical trial |
Clinical trial |
| 778364 |
Defactinib |
PK:FAK |
Clinical trial |
Clinical trial |
| 778365 |
EPZ-5676 |
DOT1L |
Clinical trial |
Clinical trial |
| 778366 |
EXEL-2280 |
PK:IGF1R,AURK,FGFR,SRC |
Clinical trial |
Clinical trial |
| 778367 |
ARRY-614 |
PK:MAPK14 |
Clinical trial |
Clinical trial |
| 778368 |
GSK-2141795 |
PK:AKT |
Clinical trial |
Clinical trial |
| 778448 |
Ombrabulin |
TUBB|Tu-frag |
Clinical trial |
Clinical trial |
| 778746 |
FH-535 |
PPARG |
Clinical trial |
Clinical trial |
| 778747 |
OTX-015 |
BRD |
Clinical trial |
Clinical trial |
| 778809 |
TAK-632 |
PK:BRAF |
Clinical trial |
Clinical trial |
| 778810 |
VS-5584 |
PK:PIK3,MTOR |
Clinical trial |
Clinical trial |
| 779218 |
CEP-28122 |
PK:ALK |
Clinical trial |
Clinical trial |
| 779404 |
RG-7388 |
MDM2 |
Clinical trial |
Clinical trial |
| 779407 |
GNE-617 |
NAMPT |
Clinical trial |
Clinical trial |
| 779408 |
Deltarasin |
PDE6D |
Clinical trial |
Clinical trial |
| 780019 |
PD183805 |
PK:EGFR,ERBB2 |
Clinical trial |
Clinical trial |
| 780020 |
spebrutinib |
PK:BTK |
Clinical trial |
Clinical trial |
| 780041 |
GSK-126 |
EZH2 |
Clinical trial |
Clinical trial |
| 780042 |
CP-724714 |
PK:ERBB2 |
Clinical trial |
Clinical trial |
| 780043 |
EPZ-004777 |
DOT1L |
Clinical trial |
Clinical trial |
| 780163 |
SOMCL-12-81 |
PK:ALK |
Clinical trial |
Clinical trial |
| 780204 |
TAS-116 |
HSP90 |
Clinical trial |
Clinical trial |
| 780205 |
dimethylfasudil |
RHO |
Clinical trial |
Clinical trial |
| 780249 |
AZD-6738 |
PK:ATR |
Clinical trial |
Clinical trial |
| 780250 |
AZD-6738 ( R,S-isomer) |
PK:ATR |
Clinical trial |
Clinical trial |
| 780290 |
SAR-260301 (enantiomer 1) |
PI3KB |
Clinical trial |
Clinical trial |
| 780291 |
SAR-260301 (enantiomer 1) |
PI3KB |
Clinical trial |
Clinical trial |
| 780404 |
AZ-505 |
SETD8|SMYD2 |
Clinical trial |
Clinical trial |
| 780812 |
BMS-906024 |
APH1|Gamma secretase |
Clinical trial |
Clinical trial |
| 780965 |
MK-0731 |
CDH16|KIF11 |
Clinical trial |
Clinical trial |
| 781008 |
maritoclax |
MCL1 |
Clinical trial |
Clinical trial |
| 781009 |
MI-773 |
MDM2 |
Clinical trial |
Clinical trial |
| 781016 |
BAY-87-2243 |
HIF1 |
Clinical trial |
Clinical trial |
| 781148 |
CEP-37440 |
PK:ALK,FAK |
Clinical trial |
Clinical trial |
| 781343 |
GDC-0994 |
PK:ERK,MAP3K,MAPK1 |
Clinical trial |
Clinical trial |
| 781344 |
NMS-1286937 |
PK:PLK1 |
Clinical trial |
Clinical trial |
| 781409 |
AGI-6780 |
IDH2 |
Clinical trial |
Clinical trial |
| 781417 |
RN-486 |
PK:BTK |
Clinical trial |
Clinical trial |
| 781468 |
CUDC-427 |
IAP |
Clinical trial |
Clinical trial |
| 781469 |
BMS-833923 |
SMO |
Clinical trial |
Clinical trial |
| 781470 |
PF-03758309 |
PK:PAK4 |
Clinical trial |
Clinical trial |
| 781514 |
AMG-925 |
PK:CDK,CDK4,CDK6,FLT3 |
Clinical trial |
Clinical trial |
| 781515 |
AMG-232 |
MDM2 |
Clinical trial |
Clinical trial |
| 781516 |
entosplenitib |
PK:SYK |
Clinical trial |
Clinical trial |
| 781626 |
Pacritinib |
PK:YK,JAK,JAK2 |
Clinical trial |
Clinical trial |
| 781627 |
GSK-2606414 |
PK:EIF2AK3 |
Clinical trial |
Clinical trial |
| 781652 |
ningetinib |
PK:MET |
Clinical trial |
Clinical trial |
| 781761 |
LY-3009120 |
PK:BRAF,RAF1 |
Clinical trial |
Clinical trial |
| 782006 |
PTC-691 |
PK:RET |
Clinical trial |
Clinical trial |
| 782007 |
AZ-628 |
PK:BRAF |
Clinical trial |
Clinical trial |
| 782017 |
H-89 |
Protein kinase A|PK:STK,AKT1 |
Clinical trial |
Clinical trial |
| 782121 |
volitinib |
PK:MET |
Clinical trial |
Clinical trial |
| 782122 |
AMG-511 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 782125 |
JNJ-54302833 |
FASN |
Clinical trial |
Clinical trial |
| 782153 |
MG-132 |
PSM |
Clinical trial |
Clinical trial |
| 782164 |
CX-5461 |
RNA polymerase I |
Clinical trial |
Clinical trial |
| 782310 |
CPI-169 |
EZH2 |
Clinical trial |
Clinical trial |
| 782362 |
PWT-33597 |
PK:PIK3,MTOR |
Clinical trial |
Clinical trial |
| 782363 |
CH-5183284 |
PK:PDGFR,FGFR,VEGFR,FGFR1,FGFR2,FGFR3 |
Clinical trial |
Clinical trial |
| 782457 |
VBY-825 |
CTSB |
Clinical trial |
Clinical trial |
| 782549 |
Defactinib |
PK:FAK |
Clinical trial |
Clinical trial |
| 782579 |
PCI-27483 |
F7 |
Clinical trial |
Clinical trial |
| 782762 |
E-3810 |
PK:PDGFR,FGFR,VEGFR |
Clinical trial |
Clinical trial |
| 782763 |
cs-1730 |
BRD |
Clinical trial |
Clinical trial |
| 783015 |
CGM-097 |
MDM2 |
Clinical trial |
Clinical trial |
| 783102 |
VS-4718 |
PK:FAK |
Clinical trial |
Clinical trial |
| 783107 |
E-7449 |
PARP1|PARP2 |
Clinical trial |
Clinical trial |
| 783249 |
JNJ-26483327 |
PK:EGFR,ERBB2,SRC,VEGFR,RET,Multikinase |
Clinical trial |
Clinical trial |
| 783272 |
JNJ-47117096 |
PK:MELK |
Clinical trial |
Clinical trial |
| 783294 |
VT-464 |
CYP17A1 |
Clinical trial |
Clinical trial |
| 783296 |
poziotinib |
PK:EGFR,ERBB2,Multikinase |
Clinical trial |
Clinical trial |
| 783332 |
EPZ-5687 |
EZH2 |
Clinical trial |
Clinical trial |
| 783333 |
SGI-1027 |
DNMT |
Clinical trial |
Clinical trial |
| 783334 |
RG-108 |
DNMT |
Clinical trial |
Clinical trial |
| 783360 |
IM-25 |
DNMT |
Clinical trial |
Clinical trial |
| 783415 |
CB-839 |
GLS |
Clinical trial |
Clinical trial |
| 783916 |
pyridoclax |
MCL1 |
Clinical trial |
Clinical trial |
| 783917 |
GSK-2879552 |
KDM1A |
Clinical trial |
Clinical trial |
| 784284 |
P-1446 |
PK:CDK,CDK1,CDK2,CDK4,CDK7,CDK9 |
Clinical trial |
Clinical trial |
| 784415 |
Danusertib |
BCR-ABL|PK:YK,AURK,FGFR,RET |
Clinical trial |
Clinical trial |
| 784590 |
altiratinib |
PK:MET,NTRK,VEGFR,TEK,KDR |
Clinical trial |
Clinical trial |
| 784591 |
CCT-251545 |
Wnt|PK:CDK19 |
Clinical trial |
Clinical trial |
| 784722 |
aldoxorubicin |
TOP2 |
Clinical trial |
Clinical trial |
| 784815 |
AZD-3147 |
PK:MTOR |
Clinical trial |
Clinical trial |
| 784817 |
A-1210477 |
MCL1 |
Clinical trial |
Clinical trial |
| 784856 |
CPI-0610 |
BRD |
Clinical trial |
Clinical trial |
| 785004 |
MLN-7243 |
UB-activating |
Clinical trial |
Clinical trial |
| 785117 |
PQR-309 |
PK:PIK3,MTOR |
Clinical trial |
Clinical trial |
| 785222 |
BMS-983970 |
APH1|Gamma secretase |
Clinical trial |
Clinical trial |
| 785299 |
EPZ-015666 |
PRMT5 |
Clinical trial |
Clinical trial |
| 785300 |
BLU-9931 |
PK:FGFR,FGFR1,FGFR2,FGFR3,FGFR4 |
Clinical trial |
Clinical trial |
| 785306 |
TAS-115 |
PK:MET,VEGFR |
Clinical trial |
Clinical trial |
| 785345 |
Bet-BAY-002 |
BRD |
Clinical trial |
Clinical trial |
| 785657 |
RX-3117 |
DNMT |
Clinical trial |
Clinical trial |
| 786098 |
BAY-1143572 |
PK:CDK,CDK9 |
Clinical trial |
Clinical trial |
| 786099 |
AZD-8835 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 786100 |
CB-5083 |
VCP |
Clinical trial |
Clinical trial |
| 786959 |
AZD-9496 |
SERD |
Clinical trial |
Clinical trial |
| 787025 |
BAY-1161909 |
IDUA |
Clinical trial |
Clinical trial |
| 787026 |
BAY-1217389 |
IDUA |
Clinical trial |
Clinical trial |
| 787027 |
EGF-816 |
PK:EGFR |
Clinical trial |
Clinical trial |
| 787038 |
AC-710 |
PK:CSF1R,PDGFR,FLT3 |
Clinical trial |
Clinical trial |
| 787039 |
MI-503 |
KMT2A |
Clinical trial |
Clinical trial |
| 787047 |
AZD-3965 |
SLC16A1|SLC16A7 |
Clinical trial |
Clinical trial |
| 787048 |
azd5582 |
IAP |
Clinical trial |
Clinical trial |
| 787081 |
SR 9243 |
NR1H1/2 |
Clinical trial |
Clinical trial |
| 787137 |
AMG-319 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 787251 |
lomeguatrib |
MGMT |
Clinical trial |
Clinical trial |
| 787252 |
TAE-226 |
PK:IGF1R,FAK |
Clinical trial |
Clinical trial |
| 787253 |
LY-3039478 |
NOTCH |
Clinical trial |
Clinical trial |
| 787269 |
SW-033291 |
HPGD |
Clinical trial |
Clinical trial |
| 787312 |
PT-2385 |
EPAS1 |
Clinical trial |
Clinical trial |
| 787326 |
GDC-0810 |
SERD |
Clinical trial |
Clinical trial |
| 787780 |
sabutoclax |
MCL1 |
Clinical trial |
Clinical trial |
| 787827 |
CFG-920 |
CYP17A1 |
Clinical trial |
Clinical trial |
| 787880 |
OTS-964 |
PK:PBK |
Clinical trial |
Clinical trial |
| 787960 |
UMI-77 |
MCL1 |
Clinical trial |
Clinical trial |
| 787962 |
KU-55933 |
PK:ATM |
Clinical trial |
Clinical trial |
| 788121 |
AZD-3759 |
PK:EGFR |
Clinical trial |
Clinical trial |
| 788186 |
Bafetinib |
BCR-ABL|PK:YK,FYN,LYN |
Clinical trial |
Clinical trial |
| 788203 |
sitravatinib |
PK:PDGFR,AXL,NTRK,KDR,RET |
Clinical trial |
Clinical trial |
| 788365 |
PF-06747775 |
PK:EGFR |
Clinical trial |
Clinical trial |
| 788794 |
A-911 |
PK:CDK,CDK9 |
Clinical trial |
Clinical trial |
| 788900 |
napabucasin |
CTNNB1|STAT3 |
Clinical trial |
Clinical trial |
| 788992 |
OICR-9429 |
WDR5 |
Clinical trial |
Clinical trial |
| 789040 |
CBL-0137 |
|
Clinical trial |
Clinical trial |
| 789041 |
GSK-295 |
CENP |
Clinical trial |
Clinical trial |
| 789042 |
LOR-253 |
KLF4|MYC|MTF1 |
Clinical trial |
Clinical trial |
| 789043 |
ARV-825 |
BRD |
Clinical trial |
Clinical trial |
| 789044 |
CCT-271850 |
IDUA |
Clinical trial |
Clinical trial |
| 789099 |
LY-3154567 |
NAMPT |
Clinical trial |
Clinical trial |
| 789223 |
AMG-337 |
PK:MET |
Clinical trial |
Clinical trial |
| 789722 |
Litronesib |
TUBB|CDH16|KIF11 |
Clinical trial |
Clinical trial |
| 789797 |
SW-044248 |
TOP1 |
Clinical trial |
Clinical trial |
| 789968 |
LY-3023414 |
PK:PIK3,MTOR |
Clinical trial |
Clinical trial |
| 789969 |
SB-202190 |
PK:MAPK14 |
Clinical trial |
Clinical trial |
| 790182 |
alofanib |
PK:FGFR |
Clinical trial |
Clinical trial |
| 790865 |
EPZ-020411 |
PRMT6 |
Clinical trial |
Clinical trial |
| 791059 |
MGCD-265 |
PK:MET,VEGFR |
Clinical trial |
Clinical trial |
| 791163 |
RG-7602 |
PK:CHEK1 |
Clinical trial |
Clinical trial |
| 791226 |
SAR-245409 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 791227 |
XL-147 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 791328 |
ARQ-092 |
PK:AKT |
Clinical trial |
Clinical trial |
| 791495 |
GDC-0339 |
PK:PIM1,PIM2,PIM3 |
Clinical trial |
Clinical trial |
| 791496 |
APR-246 |
Apo |
Clinical trial |
Clinical trial |
| 791648 |
PF-2771 |
CENP |
Clinical trial |
Clinical trial |
| 791783 |
eFT-508 |
MKNK1/2 |
Clinical trial |
Clinical trial |
| 791785 |
Sapacitabine |
Ds |
Clinical trial |
Clinical trial |
| 791966 |
CFI-400945 |
PK:PLK1 |
Clinical trial |
Clinical trial |
| 791967 |
TAK-659 (isomer 1) |
PK:SYK |
Clinical trial |
Clinical trial |
| 791968 |
TAK-659 (isomer 1) |
PK:SYK |
Clinical trial |
Clinical trial |
| 792847 |
INCB-047775 |
PK:AKT |
Clinical trial |
Clinical trial |
| 792849 |
itacitinib |
PK:JAK1 |
Clinical trial |
Clinical trial |
| 792955 |
GSK-2194069 |
FAS|FASN |
Clinical trial |
Clinical trial |
| 792956 |
AZD-0156 |
PK:ATM |
Clinical trial |
Clinical trial |
| 792969 |
VX-984 |
PK:PRKDC |
Clinical trial |
Clinical trial |
| 792970 |
KPT-9274 |
PK:PAK4 |
Clinical trial |
Clinical trial |
| 792971 |
CC-223 |
PK:MTOR |
Clinical trial |
Clinical trial |
| 792987 |
GDC-0084 |
PK:PIK3,MTOR |
Clinical trial |
Clinical trial |
| 792996 |
ARQ-087 |
PK:FGFR |
Clinical trial |
Clinical trial |
| 792997 |
ARQ-087_Peak 2 |
|
Clinical trial |
Clinical trial |
| 793103 |
ABBV-075 |
BRD |
Clinical trial |
Clinical trial |
| 793148 |
RX-5902 |
|
Clinical trial |
Clinical trial |
| 793149 |
BAY-876 |
SLC2A1 |
Clinical trial |
Clinical trial |
| 793150 |
ensartinib |
PK:ALK |
Clinical trial |
Clinical trial |
| 793151 |
CC-115 |
PK:MTOR |
Clinical trial |
Clinical trial |
| 793322 |
naquotinib |
PK:EGFR |
Clinical trial |
Clinical trial |
| 793323 |
BGB-283 |
PK:BRAF |
Clinical trial |
Clinical trial |
| 793324 |
BAY-1125976 |
PK:AKT,AKT2 |
Clinical trial |
Clinical trial |
| 793430 |
CPI-1205 |
EZH2 |
Clinical trial |
Clinical trial |
| 793585 |
LY-3177833 |
PK:CDC7,CDK7 |
Clinical trial |
Clinical trial |
| 793677 |
ASP-5878 |
PK:FGFR |
Clinical trial |
Clinical trial |
| 793679 |
CNDAC |
|
Clinical trial |
Clinical trial |
| 793726 |
CCT-245737 |
PK:CHEK1 |
Clinical trial |
Clinical trial |
| 793727 |
CCT-251921 |
PK:CDK,CDK19 |
Clinical trial |
Clinical trial |
| 794109 |
LGH-447 |
PK:PIM1 |
Clinical trial |
Clinical trial |
| 794442 |
PQR-620 |
PK:MTOR |
Clinical trial |
Clinical trial |
| 794443 |
KPT-8602 |
XPO1 |
Clinical trial |
Clinical trial |
| 794487 |
BAY-1436032 |
IDH1 |
Clinical trial |
Clinical trial |
| 794589 |
NTRC-0066-0 |
PK:TTK |
Clinical trial |
Clinical trial |
| 794590 |
BAY-1082439 |
PK:PIK3 |
Clinical trial |
Clinical trial |
| 794646 |
AMG-51 |
PK:MET |
Clinical trial |
Clinical trial |
| 795067 |
IPI-549 |
|
Clinical trial |
Clinical trial |
| 795142 |
M2698 |
PK:AKT,AKT1,AKT2,AKT3 |
Clinical trial |
Clinical trial |
| 795384 |
serabelisib |
|
Clinical trial |
Clinical trial |
| 795718 |
BLU-554 |
PK:FGFR,FGFR4 |
Clinical trial |
Clinical trial |
| 795781 |
GSK-2795039 |
|
Clinical trial |
Clinical trial |
| 796100 |
PF-06840003 |
IDO1 |
Clinical trial |
Clinical trial |
| 796101 |
ABC-294640 |
SPHK2 |
Clinical trial |
Clinical trial |
| 796433 |
PF-04136309 |
|
Clinical trial |
Clinical trial |
| 797172 |
A-1331852 |
|
Clinical trial |
Clinical trial |
| 797393 |
AT-265 |
HSP90 |
Clinical trial |
Clinical trial |
| 797653 |
WT-161 |
HDAC |
Clinical trial |
Clinical trial |
| 797769 |
ABC-1183 |
|
Clinical trial |
Clinical trial |
| 797770 |
CEP-40783 |
|
Clinical trial |
Clinical trial |
| 797771 |
ulixertinib |
PK:ERK |
Clinical trial |
Clinical trial |
| 797772 |
selonsertib |
PK:MAP3K5 |
Clinical trial |
Clinical trial |
| 797932 |
PLX-8394 |
PK:BRAF |
Clinical trial |
Clinical trial |
| 797933 |
tirabrutinib |
PK:BTK |
Clinical trial |
Clinical trial |
| 797934 |
Plinabulin |
|
Clinical trial |
Clinical trial |
| 797938 |
AZD-5153 |
|
Clinical trial |
Clinical trial |
| 798200 |
TP-0903 |
PK:AXL |
Clinical trial |
Clinical trial |
| 798201 |
VH-298 |
VHL |
Clinical trial |
Clinical trial |
| 798202 |
fenebrutinib |
PK:BTK |
Clinical trial |
Clinical trial |
| 798303 |
BPTES |
GLS |
Clinical trial |
Clinical trial |
| 798304 |
EC-330 |
MDM2 |
Clinical trial |
Clinical trial |
| 798517 |
SAR-20347 |
PK:TYK2 |
Clinical trial |
Clinical trial |
| 798799 |
GS-9901 |
|
Clinical trial |
Clinical trial |
| 798846 |
S-63845 |
|
Clinical trial |
Clinical trial |
| 799644 |
DDP-38003 |
|
Clinical trial |
Clinical trial |
| 799645 |
Aurigene Cmp 4 |
|
Clinical trial |
Clinical trial |
| 799771 |
BMS-988205 |
IDO1 |
Clinical trial |
Clinical trial |
| 799908 |
GNE-140 |
LDHA |
Clinical trial |
Clinical trial |
| 800019 |
PF-06821497 |
EZH2 |
Clinical trial |
Clinical trial |
| 800030 |
LXS-196 |
PK:PRKCA |
Clinical trial |
Clinical trial |
| 800283 |
H3B-6527 |
PK:FGFR |
Clinical trial |
Clinical trial |
| 800404 |
GSK-3326595 |
PRMT5 |
Clinical trial |
Clinical trial |
| 800522 |
TPX-0005 |
PK:ROS1,ALK |
Clinical trial |
Clinical trial |
| 800525 |
BAY-1895344 |
PK:ATR |
Clinical trial |
Clinical trial |
| 800729 |
GDC-0077 |
|
Clinical trial |
Clinical trial |
| 800888 |
CFI-402257 |
IDUA|PK:TTK |
Clinical trial |
Clinical trial |
| 800890 |
MSC-2530818 |
PK:CDK |
Clinical trial |
Clinical trial |
| 800892 |
evobrutinib |
PK:BTK |
Clinical trial |
Clinical trial |
| 800893 |
milademetan |
MDM2 |
Clinical trial |
Clinical trial |
| 801089 |
PRN-1371 |
PK:FGFR |
Clinical trial |
Clinical trial |
| 801230 |
BMS-986158 |
|
Clinical trial |
Clinical trial |
| 801661 |
TAK-931 |
PK:CDC7 |
Clinical trial |
Clinical trial |
| 801812 |
CPI-444 |
|
Clinical trial |
Clinical trial |
| 801813 |
AZD-4205 |
PK:JAK |
Clinical trial |
Clinical trial |
| 802100 |
ON-123300 |
PK:CDK,RET |
Clinical trial |
Clinical trial |
| 802101 |
AZD-4635 |
|
Clinical trial |
Clinical trial |
| 802450 |
BAY-1251152 |
|
Clinical trial |
Clinical trial |
| 802451 |
LY-3200882 |
|
Clinical trial |
Clinical trial |
| 802548 |
AZD-5069 |
CXCR2 |
Clinical trial |
Clinical trial |
| 802820 |
FT-1518 |
PK:MTOR |
Clinical trial |
Clinical trial |
| 802821 |
PQR-530 |
PK:MTOR |
Clinical trial |
Clinical trial |
| 802822 |
nedisertib |
|
Clinical trial |
Clinical trial |
| 803014 |
tenalisib |
|
Clinical trial |
Clinical trial |
| 803247 |
CB-1158 |
|
Clinical trial |
Clinical trial |
| 803248 |
MTX-211 |
PK:EGFR |
Clinical trial |
Clinical trial |
| 803408 |
EED-226 |
EED |
Clinical trial |
Clinical trial |
| 803409 |
BAY-1816032 |
PK:BUB1 |
Clinical trial |
Clinical trial |
| 803410 |
LY-3214996 |
PK:ERK |
Clinical trial |
Clinical trial |
| 803552 |
SGN-2FF |
|
Clinical trial |
Clinical trial |
| 803600 |
AG-881 |
IDH1|IDH2 |
Clinical trial |
Clinical trial |
| 803601 |
LYC-55716 |
|
Clinical trial |
Clinical trial |
| 803789 |
AZD-1390 |
PK:ATM |
Clinical trial |
Clinical trial |
| 803790 |
Aurigene Cpm 16 |
|
Clinical trial |
Clinical trial |
| 804040 |
E-7046 |
|
Clinical trial |
Clinical trial |
| 804041 |
AMG-176 |
|
Clinical trial |
Clinical trial |
| 804253 |
pamiparib |
PARP1|PARP2 |
Clinical trial |
Clinical trial |
| 804254 |
SHP-099 |
PTPN11 |
Clinical trial |
Clinical trial |
| 804518 |
BAY-1163877 |
PK:FGFR |
Clinical trial |
Clinical trial |
| 804520 |
HDM-201 |
MDM2 |
Clinical trial |
Clinical trial |
| 804521 |
S-222611 |
PK:EGFR,ERBB2 |
Clinical trial |
Clinical trial |
| 804861 |
ASTX-660 |
IAP |
Clinical trial |
Clinical trial |
| 804862 |
EPZ-031686 |
SMYD3 |
Clinical trial |
Clinical trial |
| 804962 |
FGF-401 |
PK:FGFR |
Clinical trial |
Clinical trial |
| 805149 |
TP-3654 |
PK:PIM1,PIM3 |
Clinical trial |
Clinical trial |
| 805500 |
SEL-120 |
PK:CDK |
Clinical trial |
Clinical trial |
| 805596 |
IDF-11774 |
|
Clinical trial |
Clinical trial |
| 805746 |
CC-671 |
PK:TTK |
Clinical trial |
Clinical trial |
| 806387 |
CYC-065 |
PK:CDK |
Clinical trial |
Clinical trial |
| 806388 |
E-7090 |
PK:FGFR |
Clinical trial |
Clinical trial |
| 806595 |
PLX-51107 |
|
Clinical trial |
Clinical trial |
| 806812 |
RG-6016 |
|
Clinical trial |
Clinical trial |
| 807047 |
LXH-254 |
PK:RAF |
Clinical trial |
Clinical trial |
| 807055 |
AZD-5991 |
|
Clinical trial |
Clinical trial |
| 807398 |
INCB-057643 |
|
Clinical trial |
Clinical trial |
| 807626 |
JNJ-3887618 |
|
Clinical trial |
Clinical trial |
| 807627 |
BMS-986195 |
PK:BTK |
Clinical trial |
Clinical trial |
| 808292 |
SGI-110 |
DNMT |
Clinical trial |
Clinical trial |
| 808507 |
PF-6459988 |
PRMT5|PK:EGFR |
Clinical trial |
Clinical trial |
| 808789 |
RG-7741 |
|
Clinical trial |
Clinical trial |
| 808790 |
AZD-0364 |
PK:ERK |
Clinical trial |
Clinical trial |
| 808792 |
CC-90003 |
PK:ERK |
Clinical trial |
Clinical trial |
| 808793 |
Real Thiol |
|
Clinical trial |
Clinical trial |
| 809099 |
EPZ-011989 |
EZH2 |
Clinical trial |
Clinical trial |
| 809100 |
RG-7112 |
MDM2 |
Clinical trial |
Clinical trial |
| 809251 |
ETC-159 |
|
Clinical trial |
Clinical trial |
| 809252 |
PF-06855800 |
PRMT5 |
Clinical trial |
Clinical trial |
| 809694 |
BOS-172722 |
|
Clinical trial |
Clinical trial |
| 809970 |
LOXO-195 |
|
Clinical trial |
Clinical trial |
| 809971 |
S-64315 |
|
Clinical trial |
Clinical trial |
| 809972 |
IACS-10759 |
|
Clinical trial |
Clinical trial |
| 809973 |
BAY-2402234 |
DHODH |
Clinical trial |
Clinical trial |
| 810114 |
vecabrutinib |
PK:BTK |
Clinical trial |
Clinical trial |
| 810341 |
PF-6459988 |
PRMT5|PK:EGFR |
Clinical trial |
Clinical trial |
| 810717 |
CG-806 |
PK:BTK |
Clinical trial |
Clinical trial |
| 811953 |
IACS-8968 |
IDO1 |
Clinical trial |
Clinical trial |
| 812052 |
CH-7057288 |
|
Clinical trial |
Clinical trial |
| 812172 |
ARS-1620 |
KRAS |
Clinical trial |
Clinical trial |
| 812415 |
ABBV-744 |
|
Clinical trial |
Clinical trial |
| 812727 |
relacorilant |
|
Clinical trial |
Clinical trial |
| 812728 |
AZD-4320 |
|
Clinical trial |
Clinical trial |
| 812901 |
PRN-1008 |
PK:BTK |
Clinical trial |
Clinical trial |
| 812926 |
TAS-6417 |
PK:EGFR |
Clinical trial |
Clinical trial |
| 812927 |
PF-06873600 |
PK:CDK |
Clinical trial |
Clinical trial |
| 812928 |
IDH-305 |
IDH1 |
Clinical trial |
Clinical trial |
| 813380 |
AZD-3229 |
|
Clinical trial |
Clinical trial |
| 813381 |
valemetostat |
EZH2 |
Clinical trial |
Clinical trial |
| 813488 |
futibutinib |
PK:FGFR |
Clinical trial |
Clinical trial |
| 813859 |
RGX-104 |
|
Clinical trial |
Clinical trial |
| 813862 |
Lapachone |
TOP2|TOP1 |
Clinical trial |
Clinical trial |
| 814025 |
LSZ-102 |
SERD |
Clinical trial |
Clinical trial |
